tiprankstipranks
Trending News
More News >
RVL Pharmaceuticals (RVLPQ)
OTHER OTC:RVLPQ
US Market

RVL Pharmaceuticals (RVLPQ) Ratios

Compare
311 Followers

RVL Pharmaceuticals Ratios

RVLPQ's free cash flow for Q2 2023 was $0.76. For the 2023 fiscal year, RVLPQ's free cash flow was decreased by $ and operating cash flow was $-2.52. See a summary of the company’s cash flow.
Ratios
TTM
Dec 22Dec 21Dec 20Dec 19
Liquidity Ratios
Current Ratio
2.89 2.95 3.10 2.27-
Quick Ratio
2.85 2.91 3.07 1.99-
Cash Ratio
2.26 2.01 2.04 1.26-
Solvency Ratio
-0.55 -0.84 -0.21 -0.61-
Operating Cash Flow Ratio
-1.92 -2.72 0.32 0.44-
Short-Term Operating Cash Flow Coverage
-20.14 -22.72 0.00 0.00-
Net Current Asset Value
$ -20.44M$ -8.56M$ -103.94M$ -175.92M-
Leverage Ratios
Debt-to-Assets Ratio
0.45 0.33 0.60 0.59-
Debt-to-Equity Ratio
1.13 0.62 2.36 2.38-
Debt-to-Capital Ratio
0.53 0.38 0.70 0.70-
Long-Term Debt-to-Capital Ratio
0.52 0.36 0.70 0.70-
Financial Leverage Ratio
2.52 1.89 3.95 4.04-
Debt Service Coverage Ratio
-7.25 -10.99 -15.60 -10.74-
Interest Coverage Ratio
-14.69 -20.60 -22.14 -15.41-
Debt to Market Cap
18.30 0.64 0.88 0.73-
Interest Debt Per Share
0.67 0.77 3.72 5.57-
Net Debt to EBITDA
-0.36 -0.10 -1.54 -0.80-
Profitability Margins
Gross Profit Margin
80.98%79.33%88.14%53.49%-
EBIT Margin
-97.75%-454.25%-326.71%-116.57%-
EBITDA Margin
-72.78%-401.93%-250.97%-92.82%-
Operating Profit Margin
-91.87%-472.85%-326.53%-116.94%-
Pretax Profit Margin
-104.00%-471.60%-341.46%-124.16%-
Net Profit Margin
-103.96%-370.95%-286.68%-112.86%-
Continuous Operations Profit Margin
-103.96%-473.40%-320.63%-112.86%-
Net Income Per EBT
99.96%78.66%83.96%90.90%-
EBT Per EBIT
113.20%99.73%104.57%106.17%-
Return on Assets (ROA)
-40.22%-44.87%-21.46%-58.48%-
Return on Equity (ROE)
-80.88%-84.61%-84.80%-236.17%-
Return on Capital Employed (ROCE)
-41.99%-66.44%-28.76%-72.47%-
Return on Invested Capital (ROIC)
-41.26%-65.00%-26.90%-65.51%-
Return on Tangible Assets
-87.97%-105.35%-28.42%-129.98%-
Earnings Yield
-2041.32%-89.25%-31.85%-74.01%-
Efficiency Ratios
Receivables Turnover
16.40 8.20 8.82 5.47-
Payables Turnover
3.93 0.96 1.05 13.14-
Inventory Turnover
12.06 4.32 1.80 5.24-
Fixed Asset Turnover
27.81 7.83 6.39 6.81-
Asset Turnover
0.39 0.12 0.07 0.52-
Working Capital Turnover Ratio
1.30 0.22 0.26 3.10-
Cash Conversion Cycle
-40.40 -252.01 -102.36 108.66-
Days of Sales Outstanding
22.25 44.49 41.40 66.78-
Days of Inventory Outstanding
30.26 84.54 202.95 69.66-
Days of Payables Outstanding
92.91 381.04 346.71 27.78-
Operating Cycle
52.51 129.03 244.35 136.44-
Cash Flow Ratios
Operating Cash Flow Per Share
-0.42 -0.81 0.29 0.64-
Free Cash Flow Per Share
-0.43 -0.84 0.24 0.56-
CapEx Per Share
<0.01 0.03 0.05 0.08-
Free Cash Flow to Operating Cash Flow
1.02 1.03 0.82 0.88-
Dividend Paid and CapEx Coverage Ratio
-50.28 -30.71 5.61 8.31-
Capital Expenditure Coverage Ratio
-50.28 -30.71 5.61 8.31-
Operating Cash Flow Coverage Ratio
-0.66 -1.15 0.08 0.12-
Operating Cash Flow to Sales Ratio
-0.76 -3.13 0.63 0.14-
Free Cash Flow Yield
-1227.44%-77.69%5.78%8.07%-
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-0.05 -1.12 -3.14 -1.35-
Price-to-Sales (P/S) Ratio
0.06 4.16 9.00 1.53-
Price-to-Book (P/B) Ratio
0.05 0.95 2.66 3.19-
Price-to-Free Cash Flow (P/FCF) Ratio
-0.08 -1.29 17.29 12.40-
Price-to-Operating Cash Flow Ratio
-0.07 -1.33 14.21 10.91-
Price-to-Earnings Growth (PEG) Ratio
>-0.01 0.04 0.04 -0.01-
Price-to-Fair Value
0.05 0.95 2.66 3.19-
Enterprise Value Multiple
-0.44 -1.14 -5.13 -2.44-
Enterprise Value
16.09M 79.94M 357.45M 543.48M-
EV to EBITDA
-0.44 -1.14 -5.13 -2.44-
EV to Sales
0.32 4.57 12.88 2.26-
EV to Free Cash Flow
-0.42 -1.41 24.73 18.40-
EV to Operating Cash Flow
-0.43 -1.46 20.32 16.19-
Tangible Book Value Per Share
-0.21 -0.09 0.05 -2.68-
Shareholders’ Equity Per Share
0.57 1.14 1.55 2.19-
Tax and Other Ratios
Effective Tax Rate
<0.01 >-0.01 0.06 0.09-
Revenue Per Share
0.55 0.26 0.46 4.58-
Net Income Per Share
-0.58 -0.96 -1.31 -5.17-
Tax Burden
1.00 0.79 0.84 0.91-
Interest Burden
1.06 1.04 1.05 1.07-
Research & Development to Revenue
0.08 0.40 0.48 0.13-
SG&A to Revenue
0.00 0.00 0.00 0.00-
Stock-Based Compensation to Revenue
0.08 0.43 0.18 0.02-
Income Quality
0.73 0.84 -0.22 -0.12-
Currency in USD